Singapore studying the feasibility, reliability of saliva tests for Covid-19
In the News
Lucence and Akribis Collaborate on COVID-19 Saliva Processing Automated Platform to Enable Mass TestingJuly 2, 2020- Singapore studying the feasibility, reliability of saliva tests for Covid-19June 25, 2020
Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected VirusJune 16, 2020
Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung CancerMay 26, 2020
Lucence announces the launch of SARS-CoV-2 RNA RT-PCR clinical testing service to support Singapore’s anti-COVID-19 efforts.May 25, 2020
